ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Theravance Biopharma (TBPH)

Technical Analysis Report for NASDAQ stock TBPH Theravance Biopharma. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock TBPH Theravance Biopharma then click here. or read Experts views on Theravance Biopharma or Forecast & share price targets of Theravance Biopharma

Theravance Biopharma Opened at 16.87 and Closed at: 16.86, which is 0.06% of previous session's close. It moved within a range of 16.85 and 16.88
The session was a Bearish session with an average volume of 369600, which is -7.71% of previous session's volumes.

  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Dead cross was found 8 days back on long term averages

Support for tomorrow is 16.84 and resistance for tomorrow is 16.87
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 16.85, 16.83 resistance for tomorrow's hourly charts is 16.88, 16.89

10 Day SMA for Theravance Biopharma (TBPH) is 16.85 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Theravance Biopharma (TBPH) is 16.9 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Theravance Biopharma (TBPH) is 16.7 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 16.37 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Theravance Biopharma is 17.11 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Theravance Biopharma is at 16.9 and 200 DMA is at 17.11, while 50 DMA and 100 DMA are at 16.7 and 16.37 respectively

Theravance Biopharma (TBPH) moving average of 20 SMA is at 16.9 and 20 EMA is at 16.87

Theravance Biopharma (TBPH) moving average of 50 SMA is at 16.7 and 50 EMA is at 16.75

Theravance Biopharma (TBPH) moving average of 100 SMA is at 16.37 and 100 EMA is at 16.72

Theravance Biopharma (TBPH) moving average of 200 SMA is at 17.11 and 200 EMA is at 16.15

Dentsply Sirona has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Dentsply Sirona, about 10.56% more returns!

Theravance Biopharma has performed better than Vanda Pharmaceuticals in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Veracyte Inc in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Tg Therapeutics in short term. Holding Theravance Biopharma could be a better choice for now!

Scynexis Inc has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Scynexis Inc, about 5.65% more returns!

Theravance Biopharma has performed better than Nektar Therapeutics in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Nucana Plc in short term. Holding Theravance Biopharma could be a better choice for now!

Aceto Corporation has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Aceto Corporation, about 7.04% more returns!

Theravance Biopharma has performed better than Akari Therapeutics in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Amarin Corporation in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Capricor Therapeutics in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Cytosorbents Corporation in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Enanta Pharmaceuticals in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Healthcare Services in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Harrow Health in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Helius Medical in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Idexx Laboratories in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma has performed better than Intuitive Surgical in short term. Holding Theravance Biopharma could be a better choice for now!

Theravance Biopharma Technical analysis of indicators

Price action analysis of Theravance Biopharma (TBPH) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.

Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up

CCI has generated a buy signal for Theravance Biopharma in short term but BUY signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Theravance Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 16.85 and Theravance Biopharma TBPH stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Theravance Biopharma TBPH stock. Volume based technical analysis of Theravance Biopharma TBPH stock is negative.

Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock TBPH Theravance Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And TBPH Experts View which covers a lot of information including buying and selling signals

TBPH future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Theravance Biopharma or View Candle Stick Charts here

Chart Theravance Biopharma (TBPH)  Technical (Analysis) Reports Theravance Biopharma [

Videos related to: Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Theravance Biopharma (TBPH)  Technical (Analysis) Reports Theravance Biopharma [

 

Back to top